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http://www.biomedcentral.com/1471-2377/12/61RESEARCH ARTICLE Open AccessQuality of life of elderly ischaemic stroke patients
one year after thrombolytic therapy. A comparison
between patients with and without thrombolytic
therapy
Leonie de Weerd1*, Gert-Jan R Luijckx2, Klaas H Groenier1 and Klaas van der Meer1Abstract
Background: An observational study to examine whether thrombolytic therapy in stroke patients realizes better
quality of life outcomes compared to patients without thrombolytic therapy one year after stroke. We also
examined whether daily functioning, mental functioning and activities improved after thrombolytic treatment.
Methods: A total of 88 stroke patients were interviewed at home one year post-stroke. Health-related quality of life
(HRQOL) was assessed using the RAND-36, disability with the Barthel Index, depression and anxiety with the
Hospital Anxiety and Depression Scale, and a questionnaire about patient way of life was completed. People aged
under 60, moving to a nursing home or with a haemorrhage were excluded.
Results: The thrombolysis group (TG) had more severe stroke (higher NIHSS) scores and were younger than the
group without thrombolytic therapy (WTG). The primary outcome was HRQOL, which was high and nearly identical
in both groups, however the TG had significantly better HRQOL for the ‘mental health’ and ‘vitality’ scales. Patients
who stopped or reduced their hobbies because of stroke had a significantly worse HRQOL.
One year after stroke, more patients in the TG were totally or severely ADL dependent (12% TG and 0% WTG,
p = 0.022). The level of dependence decreased in the TG (p = 0.042) and worsened in the WTG (p< 0.001) after one
year. Being more dependent is related to diminishing daily occupations in both groups. In the TG the level of
dependence had less impact on visiting family and friends and going on holiday. The prevalence of anxiety
disorder and depression was low compared to other studies and there is no significant difference between the
two groups.
Conclusion: No major differences in the primary outcome (HRQOL) could be found between the two groups. In
addition, no essential difference could be found in mental functioning and participation. We expected that patients
undergoing thrombolytic therapy would have worse quality of life because of the greater initial severity of their
stroke. Therefore, thrombolytic therapy seems to be of great importance in achieving better quality of life in
ischemic stroke patients who respond to this therapy.Background
Acute ischaemic stroke is the second most common
cause of death worldwide and a major cause of disability
[1,2]. Each year, 19,000 men and 22,000 women in the
Netherlands suffer a stroke [3]. The average age of
patients suffering a stroke is seventy in men and* Correspondence: l.de.weerd@umcg.nl
1Department of General Practice, University of Groningen, Antonius
Deusinglaan 1, 9713 AV Groningen, The Netherlands
Full list of author information is available at the end of the article
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Commons Attribution License (http://creativec
reproduction in any medium, provided the orseventy-five in women [4]. The elderly are particularly
affected by strokes. Because of future aging it is import-
ant to pay greater attention to prevention and aftercare
for stroke patients [5,6].
Currently, the interventions available to improve out-
comes after ischaemic stroke are: admission to a stroke
unit, the use of aspirin within 48 hours after stroke onset
and treatment with intravenous tissue plasminogen acti-
vator (tPA) within 4.5 hours after stroke onset. Of these
interventions, thrombolysis is the most effective and hasral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ment of stroke patients [7].
However, only a small percentage of ischaemic stroke
patients receive tPA [8]. ‘The Netherlands stroke survey’
showed that 7% of all patients referred to a hospital with
acute ischemic stroke ultimately received thrombolytic
therapy [9]. Lack of patient familiarity with stroke symp-
toms and correct responses, late hospital arrival, the nar-
row therapeutic window and variance in the selection of
patients for thrombolysis are among the factors that
contribute to this under-treatment [7]. A feared compli-
cation of thrombolytic therapy is intracranial haemor-
rhaging. Symptomatic intracranial haemorrhage occurs
in 1.7 to 8.0% of treated patients [7]. Despite this com-
plication, thrombolytic therapy is still very effective and
there is no reason to withhold this treatment from
stroke patients, even elderly patients [10]. Stroke
patients treated with tPA have after a year an almost
twice as good a chance of a good functional outcome
and are more likely to have minimal or no disability
compared to those without such treatment [11].
A stroke affects patients’ lives in many different ways,
not only physically but also through a range of emo-
tional, psychological, cognitive and social consequences.
The seriousness of post-stroke physical and mental
impairments influences quality of life. As stroke mortal-
ity declines, more patients have to live with multiple
handicaps and impairments. Therefore, improving the
quality of life and paying greater attention to rehabilita-
tion is increasingly important [6,12,13].
After discharge from hospital about 50% of patients re-
turn to their homes. Their general practitioners (GP) as-
sist patients in coping with disabilities and psychological
problems and manage secondary prevention [14]. Little
is known about the long-term outcomes for Dutch
patients after stroke, especially when compared to
patients treated with thrombolysis. Most studies concen-
trate on functional outcomes in the acute or rehabilita-
tion phase [15]. Accordingly, it is important for GPs to
be aware of the primary care outcomes and what contri-
butes to a good prognosis after a stroke [6,12]. In
addition, it is important to know what the differences
are between patients who received thrombolysis and
patients who did not receive this kind of treatment.
As little is known about late physical and psychological
consequences of ischemic stroke in primary care patients
in the Netherlands, it is hard to determine whether
patients are receiving quality aftercare and to determine
whether thrombolysis treatment is of added value for a
longer period after stroke.
The purpose of this study is to examine the quality of
life one year after stroke of patients treated with
thrombolysis compared to patients without thrombolytic
therapy who returned to their homes immediately afterdischarge from hospital. We expected patients with
thrombolytic therapy to experience a worse quality of
life because of the greater initial severity of their stroke.
Secondary outcomes include functioning, daily occupa-
tions, anxiety and depression.Methods
Study design
The study included two groups of patients, namely all the
ischemic stroke patients admitted to the University Med-
ical Center Groningen, the Netherlands (UMCG) who
were treated with thrombolysis between November 2007
and November 2008, and all the ischemic stroke patients
admitted to a community hospital, Martini Hospital Gro-
ningen, the Netherlands, who were not treated with
thrombolysis, between November 2006 and November
2007. We selected patients from two different hospitals
because the UMCG acts as a comprehensive stroke centre
to which patients from the region eligible for thrombolytic
treatment are transported. The Martini Hospital acts as a
community hospital where stroke patients ineligible for
thrombolytic treatment are admitted.
The exclusion criteria for the study were being younger
than 60 (because of this group’s profile in daily functioning
and social life, and to create a more homogenous group),
and referral to a nursing home, rehabilitation centre or an-
other hospital department after being discharged from the
hospital (because the GP stops being responsible for med-
ical care under such circumstances). People already living
in a retirement home before their stroke could enter the
study. The study was approved by the MEC (medical eth-
ical committee) of the UMCG and informed consent was
obtained from all patients.
After informed consent, all patients were visited at
home one year after stroke. Patients were interviewed in
person by a trained medical practitioner and standar-
dized questionnaires were completed. Clinical details –
including stroke severity, comorbidity and vascular risk
factors before stroke, medication and demographic infor-
mation – were obtained from the medical records.
Stroke severity was determined by the National Institute
of Health Stroke Scale (NIHSS) [16].Measures at 12 months
The Barthel Index (BI) was used to assess disability in
the patients. The BI measures the level of independence
in ADL and yields a score ranging from 0 (functionally
totally dependent) to 21 (functionally totally independ-
ent). In our questionnaire, patients were awarded three
points for eating independently rather than two points
in the original questionnaire. The sensitivity and reliabil-
ity of the BI are high for stroke patients [17,18].
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quality of life (HRQOL). The RAND-36 consists of 36
questions and comprises 8 health scales (physical func-
tion (FF), role limitations physical (Rlf ), social function-
ing (SF), role limitations emotional (Rle), bodily pain
(BP), general health (GH), vitality (Vit) and mental
health (MH)). The health scales range from 0 (poor
HRQOL) to 100 (good HRQOL). The RAND-36 is a re-
liable and valid measure for determining HRQOL in
stroke patients [19-21].
To identify the possible and probable presence of de-
pression and anxiety disorders in our patients, the Hos-
pital Anxiety and Depression Scale (HADS) was used.
The HADS is a 14-item scale divided into depression
and anxiety subscales. The possible scores for depression
or anxiety range from 0 to 21. A score of 8 to 10 corre-
sponds to possible anxiety disorder or depression and a
score of 11 or higher indicates the probable presence of
a mood disorder [22,23].
In addition, patients were asked about changes in their
habits and daily occupations after their stroke, such as
smoking, alcohol consumption, housekeeping, physical ex-
ercise, hobbies, reading, visiting family and friends, mem-
bership of clubs or associations and going on holiday.
Statistical analysis
SPSS 15 for Windows (SPSS Inc., Chicago) was used
for statistical analysis. Statistical significance was set at
p< 0.05 (2-sided). For comparisons between groups, we
used the following non-parametric tests: Mann–Whit-
ney, Kruskall-Wallis and Analysis of Variance (ANOVA)
using the Rank Transform method. The Rank Trans-
form method consists of replacing the observations by
their ranks in the combined sample and performingThese groups of patients were excluded in
A part of these patients were included in t






















Figure 1 Flow chart of selection of patients.one of the standard analysis of variance procedures on
these ranks [24]. The differences between groups were
corrected for age and seriousness of stroke as a covariate.
Because of the skewed distribution of the severity of stroke
scale, the scores for this scale were converted to percentile
ranks and then to normal curve equivalent (NCE) scores.
Fisher’s exact test was used for categorical variables.
To describe the number of patients who changed their
habits due to stroke, their responses were categorized
into ‘more’, ‘less’, ‘as much as before’ or ‘quit’.
Despite the relatively large number of statistical tests ap-
plied, we decided not to correct for ‘multiple testing’ (for
instance by means of the Bonferroni method). Instead, the
p-values are simply presented as an indication of the
strength of the evidence. Furthermore, since all patients
admitted to the two hospitals during the study period were
included, no formal power analysis was performed.Results
Baseline characteristics
In total, two hundred and thirty-five patients were diag-
nosed with ischemic stroke, of which eighty-two patients
received thrombolytic treatment. Ultimately, eighty-eight
interviews were conducted, with the reasons for exclu-
sion shown in Figure 1. In the TG there were seven
patients who could not participate because one patient
was admitted to the intensive care unit at time of inter-
view, one patient was living in Germany, two patients
could not be contacted and three patients did not want
to participate. In the WTG six patients could not partici-
pate, because one patient was rehabilitating from a hip
fracture and the five other patients did not feel it neces-
sary to participate because they were doing fine. the study
his study



















Table 1 Baseline characteristics of the study population
Variables Thrombolysis (%) Without (%) p
Patients included 33 55
Gender* 0.008
- Men 24 (72.7) 32 (58.2)
- Women 9 (27.3) 23 (41.8)
Age, average (range)# 73.6 (61-85) 77.2 (65-91) 0.025
Living situation*
- Living alone 7 (21.2) 30 (55.5) 0.003
- Living with a partner 26 (78.8) 25 (45.5)
Brain hemisphere*
- Left side 20 (39.4) 16 (29.1) 0.007
- Right side 13 (60.6) 34 (61.8)
- Unknown 5 (9.1)






1 (3.0) 6 (10.9%) 0.248
- No risk factors 23 (69.7) 27 (49.1) 0.076
- Hypertension 13 (39.4) 6 (10.9) 0.003
- Hypercholesterolemia 4 (12.1) 12 (21.8) 0.392
- Diabetes 9 (27.3) 16 (29.1) 1.000
- Smoking 9 (27.3) 14 (25.5) 1.000
- Ischemic heart disease 9 (27.3) 13 (23.6) 0.801
- Stroke/TIA 7 (21.2) 5 (9.1) 0.122
- Atrial fibrillation 1 (3.0) 2 (3.6) 1.000
* Fisher’s exact test, #One-way ANOVA.
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population are provided in Table 1. In the thrombolysis
group there are significantly more men, the mean age is
lower, the NIHSS is higher, more patients had strokes to
the left hemisphere and more patients were living with a
partner. In the following results we corrected for stroke
severity and age.
Health-related quality of life (RAND-36)
The primary outcome of this study was health-related
quality of life. In Table 2 a comparison is made between
the TG and the WTG with respect to HRQOL. HRQOL
is nearly identical in these two groups, except for the
scales ‘Mental Health’ and ‘Vitality’. Patients in the
thrombolysis group have a significantly better HRQOL
for these two scales (p = 0.024, p = 0.024, resp.).
In Table 3 the interaction effects between the groups
and the change in activities with respect to the RAND-
36 are given, to explore to what extent differencesbetween the two treatment modalities are mediated by
these variables. The results were corrected for differ-
ences in age and stroke severity. There are two signifi-
cant interaction effects between physical activity and the
treatment groups (TG and WTG) for the health scale
‘Role limitations – emotional’ (p = 0.011) and between
reading and the treatment groups for the health scale
‘Vitality’ (p = 0.033).Level of dependence according to the barthel index
At discharge from hospital, 70% of TG and 98% of the
WTG are not dependent or slightly dependent
(p = 0.001). One year after stroke this percentage is 88%
(TG) and 96% (WTG) (p = 0.022). Immediately after dis-
charge, 13% of the TG was severely or totally dependent;
after one year this percentage was 12%. In the WTG
none of the patients were totally or severely dependent
at discharge or after one year.
When we compare the mean Barthel Index after one
year, there is no significant difference between the TG
(M=18.03) and the WTG (M=18.76) (p = 0.620). The
mean Barthel Index in the TG after one year (M= 18.03)
is significantly higher than at discharge from hospital
(M= 15.97) (p = 0.042) and significant lower (M= 19.89
at discharge and M=18.76 after one year) (p< 0.0005)
in the WTG.
Being more dependent is related to diminishing daily
occupations (significant for housekeeping in both groups
(p< 0.05). An experienced decline in QOL is not related
to being more dependent (Table 4).
Using the Rank Transform ANOVA, we investigated
whether there were any interaction effects between the
treatment modality (TG or WTG) and demographic fac-
tors and changes in activities with respect to the BI
scores, to explore to what extent differences between the
two treatment modalities are mediated by these vari-
ables. Moreover, all analyses were corrected for age and
stroke severity. There are only two significant interaction
effects, namely for visiting family and friends (p = 0.002)
and vacation (p = 0.001). Changes in these two factors
led to higher BI scores for the T patients compared to
the WT patients (Table 4).Mood disorder (HADS)
In this study, 3% of the TG and 3.6% of the WTG had a
history of depression.
One year after stroke, 9.1% of the TG and 5.3% of the
WTG had probable depression. Additionally, depression
is possible in 6.1% of the TG and 7% of the WTG. How-
ever, there is no significant difference in the prevalence
of depression between the two groups (p = 0.055).
According to the HADS scores, one year after stroke,
6.1% of the TG and 5.3% of the WTG probably had an
Table 2 Rand-36 comparison in the two study groups
Rand-36 Thrombolysis Without
Median (range), [95% CI] Median (range), [95% CI] p*
Physical functioning 65 (0-100) [50-85] 62.5 (5-100) [55-80] 0.762
Social functioning 100 (0-100) [75-100] 100 (25-113) [75-100] 0.716
Role limitations – physical 50 (0-100) [25-75] 75 (0-100) [50-75] 0.346
Role limitations – emotional 100 (0-100) [100-100] 100 (0-100) [100-100] 0.467
Mental Health 88 (20-100) [80-96] 80 (16-100) [72-84] 0.024
Vitality 85 (5-100) [65-90] 65 (15-95) [60-70] 0.024
Bodily Pain 89.8 (0-100) [69.4-100] 89.8 (12-100) [69.4-100] 0.892
General Health 65 (0-100) [55-80] 65 (0-100) [55-75] 0.427
*Mann–Whitney test.
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WTG possibly had an anxiety disorder. However, no sta-
tistically significant difference in prevalence between the
two groups could be found (p = 0.634).
Daily occupations
The percentages of patients who had to stop or diminish
different activities are given in Table 5. There are no sta-
tistically significant differences between the two groups,
except for hobbies. Significantly more patients in the TG
had to stop their hobbies after stroke.
Discussion and conclusion
Discussion
In this study we examined quality of life of ischaemic
stroke patients one year after thrombolytic therapy com-
pared to patients who had not undergone thrombolytic
therapy.
Unfortunately, the two groups are not fully compar-
able. The severity of the stroke experienced by the pa-
tient group that underwent thrombolytic therapy was
significantly greater than in the group without treat-
ment. A possible explanation is that more severe stoke
patients reach the hospital earlier and are eligible for
thrombolysis [25,26]. The WTG was older and there
were more women in this group, possibly because
women may be less likely to reach hospital for thromb-
olysis treatment in time [27,28]. However, we corrected
for the differences between the two groups. Risk factors
present before stroke were approximately the same in
both groups.
The primary outcome was health-related quality of life
one year post-stroke. HRQOL in both groups was as
high as in the Dutch elderly population [21] and is
nearly identical in both groups, although patients in the
thrombolysis group have a significantly better HRQOL
for the ‘Mental health’ and ‘Vitality’ scales. Other studies
report lower HRQOL after one year [29-31]. However,these studies included all patients with ischemic strokes,
so they possibly studied more severely impaired stroke
patients. It is known that higher ADL independence cor-
relates to a worse HRQOL [29-32]. One possible explan-
ation for the high scores on the RAND-36 is that a
stroke has such an impact on life that patients one year
post-stroke see quality of life in greater perspective. Dur-
ing their interviews, patients made comments such as: ‘it
could have been worse’.
We examined whether there was a difference between
the two groups in stopping or diminishing different ac-
tivities. There was only a significant difference with re-
spect to hobbies. This is possibly due to the fact that
patients in the TG are younger and had more hobbies
that they could practise before their strokes. Patients
who stopped or reduced various activities have a signifi-
cantly worse HRQOL. To increase HRQOL further, brief
psychosocial intervention and antidepressant treatment
could reduce post-stroke depression and improve func-
tional outcomes [6,33]. Starting community-based re-
habilitation programmes could also help by increasing
the patients’ activity levels and give them greater satis-
faction [34,35].
One year after stroke, more patients in the TG are
ADL dependent. It is remarkable that one year after
stroke, the average score on the BI in the TG has be-
come higher than at discharge from hospital and lower
in the WTG. This effect could be due to thrombolysis
treatment [1,36]. Another explanation is that there are
significantly more men in the TG. Some studies show
that men are more likely than women to achieve func-
tional independence [27,37].
Being more dependent is related to diminishing daily
occupations in both groups [6,38]. It is important to pay
attention to this in rehabilitation [6,39].
There were two significant interaction effects with re-
spect to BI between the TG and WTG, namely for visit-
ing family and friends and going on holiday. In the TG
Table 3 RAND-36 interactions between the TG and WTG
and activities
HRQOL Activities p#








































p# corrected for stroke severity and age.
# Interaction rank transform ANOVA.
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family and friends and going on holiday. This could be
because patients in the TG are younger. In the WTG
there is a significant relationship between ADL inde-
pendence and loss of social contacts. This has also been
observed in other studies [6,40]. It is important to con-
sider this in the rehabilitation of stroke patients because
life satisfaction is significantly related to social activity
and ADL independence [41,42].
After one year there is no significant difference in
the prevalence of depression between the TG and the
WTG. There is an indication of depression in about
12-15% for both groups. This is less than other studies
indicate, namely 18-60% [43-45]. There also is no sig-
nificant difference between the two groups with re-
spect to anxiety disorder. About 9-18% have an
anxiety disorder. This percentage is also less than was
found in other studies, namely 25-50% [43]. It there-
fore seems that thrombolysis has no apparent effect on
the prevalence of depression or anxiety disorder. It is
nonetheless important to screen patients for depression
or anxiety disorder because this significantly influences
their quality of life [6,46]. By treating these diseases,
HRQOL can be influenced positively.
In this study we used the HADS to measure depres-
sion and anxiety disorder, meaning that the percentages
reported are only an indication. To diagnose these dis-
eases, more extensive tests should be performed.
This study has several limitations. First, the study
groups were relatively small because of the selection cri-
teria. As a consequence, only large differences in the
outcome variables resulted in statistically significant
results. Another study also reported good health-related
QOL for patients after thrombolysis [13]. Therefore, we
expected minor differences in QOL after thrombolysis
compared to those who did not receive this treatment.
We may need to study a larger group of patients to de-
tect a significant improvement in QOL after thromboly-
sis. Moreover, we only interviewed patients in the TG
who went home immediately after discharge from hos-
pital. They were probably good responders to thrombo-
lytic therapy. We did not include those patients in the
TG who were not discharged home and who were prob-
ably non-responders to thrombolytic therapy.
Secondly, the participants were distributed to two
groups depending on which hospital they were admitted
to, because the UMCG acts as a comprehensive stroke
centre to which patients from the region eligible for
thrombolytic treatment are transported. The Martini
Hospital acts as a community hospital where stroke
patients ineligible for thrombolytic treatment are admit-
ted. Although the aftercare available to the two groups
was the same, we could not completely rule out the con-
founding factor ‘hospital’. For stronger generalizations,
Table 4 Functioning according to demographic factors, change in activities and aftercare
Variables Thrombolysis Without
N Median BI (range) p* N Median BI (range) p* p #
Gender2 Male 24 20 (4-20) 0.310 23 20 (12-20) 0.155 0.227
Female 9 19 (9-20) 32 19 (13-20)
Social situation2 Living alone 7 18 (18-20) 0.355 30 19.5 (13-20) 0.405 0.419
Living with partner 26 20 (4-20) 23 20 (12-20)
Stroke location2 Left side 13 20 (9-20) 0.561 34 20 (13-20) 0.851 0.096
Right side 20 20 (4-20) 16 19.5 (12-20)
Unknown 0 5 20 (18-20)
Housekeeping1 More 1 20 (20-20) 0.005 5 20 (18-20) <0.001 0.612
As much as before 21 20 (18-20) 25 20 (13-20)
Less 7 20 (8-20) 16 18 (15-20)
Quit 4 9 (4-18) 8 17 (12-19)
Physical activity1 More 1 20 (20-20) 0.107 2 20 (20-20) 0.003 0.139
As much as before 16 20 (18-20) 18 20 (16-20)
Less 15 20 (8-20) 30 20 (12-20)
Quit 1 4 (4-4) 4 14 (12-17)
Hobbies1 More 0 0.005 1 20 (20-20) 0.662 0.866
As much as before 17 20 (18-20) 34 20 (13-20)
Less 7 20 (18-20) 18 20 (12-20)
Quit 9 18 (4-20) 1 18 (18-18)
Visiting1 More 1 20 (20-20) 0.058 0 0.001 0.002
As much as before 25 20 (9-20) 37 20 (15-20)
Less 5 20 (8-20) 14 18.5 (13-20)
Quit 2 6.5 (4-9) 3 15 (12-17)
Vacation More 0 0.182 2 20 (20-20) 0.007 0.001
As much as before 18 20 (9-20) 25 20 (13-20)
Less 9 20 (9-20) 12 20 (18-20)
Quit 6 18.5 (4-20) 15 17 (12-20)
Experienced quality of life2 Increased 2 20 (20-20) 0.107 0 0.505 0.169
The same 16 20 (18-20) 37 20 (13-20)
Diminished 15 19 (4-20) 17 19 (12-20)
p# corrected for stroke severity and age.
* Kruskall-Wallis1 and Mann-Whitney2 test, # Interaction rank transform ANOVA.
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tiple hospitals with and without thrombolytic treatment
should be studied.
One of this study’s strengths is the method of data ac-
quisition. We visited patients at home to complete the
questionnaires together. A lot of information was
obtained through conversation, not only through the ac-
tual talking but also by being able to demonstrate.
Another strength is the fact that a single researcher
visited all the patients and that we used standardized
questionnaires. This avoided different interpretations of
the results.Conclusion
To conclude, this study found no essential differences
in health-related quality of life between patients
with or without thrombolytic therapy. Independence
increased in the patients with thrombolytic therapy.
We expected that patients with thrombolytic therapy
(with initial worse stroke severity) would have worse
HRQOL, functioning/mental functioning and participa-
tion. Therefore, thrombolytic therapy appears to be of
great value to achieving good quality of life in ische-
mic stroke patients. Perhaps quality of life can be
improved further for both groups if aftercare is more
Table 5 Change in the frequency of daily occupations
Daily Occupations Thrombolysis (%) No Thrombolysis (%) p*
Physical exercise More 3.0 8.8 0.434
The same 63.6 43.9
Less 21.2 28.1
Quit 12.1 14.0
Housekeeping More 3.0 3.5 0.546
The same 48.5 31.6
Less 45.5 52.6
Quit 3.0 7.0
Hobbies More 0.0 1.8 0.002
The same 51.5 59.6
Less 21.2 31.6
Quit 27.3 1.8
Visiting More 3.0 0.0 0.463
The same 75.8 64.9
Less 15.2 24.6
Quit 6.1 5.3
Holidays More 0.0 3.5 0.544
The same 54.5 43.9
Less 27.3 21.1
Quit 18.2 26.3
Reading More 3.0 3.5 0.398
The same 69.7 77.2
Less 24.2 10.5
Quit 3.0 3.5
* Fisher’s exact test.
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